Kamper-Jørgensen, M., Rostgaard, K., Glaser, S. L., Zahm, S. H., Cozen, W., Smedby, K. E., Sanjosé, S., Chang, E. T., Zheng, T., La Vecchia, C., Serraino, D., Monnereau, A., Kane, E. V., Miligi, L., Vineis, P., Spinelli, J. J., McLaughlin, J. R., Pahwa, P., Dosman, J. A., ... Hjalgrim, H. (2013). Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. https://doi.org/10.1093/annonc/mdt218
Kamper-Jørgensen, M, Rostgaard, K, Glaser, SL, Zahm, SH, Cozen, W, Smedby, KE, Sanjosé, S, Chang, ET, Zheng, T, La Vecchia, C, Serraino, D, Monnereau, A, Kane, EV, Miligi, L, Vineis, P, Spinelli, JJ, McLaughlin, JR, Pahwa, P, Dosman, JA, Vornanen, M, Foretova, L, Maynadie, M, Staines, A, Becker, N, Nieters, A, Brennan, P, Boffetta, P, Cocco, P & Hjalgrim, H 2013, 'Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph)', Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. https://doi.org/10.1093/annonc/mdt218
Kamper-Jørgensen M, Rostgaard K, Glaser SL, Zahm SH, Cozen W, Smedby KE et al. Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013 sep. doi: 10.1093/annonc/mdt218
@article{ce5fae5e7bab454f967bfa5dabdec08c,
title = "Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph)",
abstract = "Background: The etiology of Hodgkin lymphoma (HL) remains incompletely characterized. Studies of the association between smoking and HL have yielded ambiguous results, possibly due to differences between HL subtypes. Patients and methods: Through the InterLymph Consortium, 12 case-control studies regarding cigarette smoking and HL were identified. Pooled analyses on the association between smoking and HL stratified by tumor histology and Epstein-Barr virus (EBV) status were conducted using random effects models adjusted for confounders. Analyses included 3335 HL cases and 14 278 controls. Results: Overall, 54.5% of cases and 57.4% of controls were ever cigarette smokers. Compared with never smokers, ever smokers had an odds ratio (OR) of HL of 1.10 [95% confidence interval (CI) 1.01-1.21]. This increased risk reflected associations with mixed cellularity cHL (OR = 1.60, 95% CI 1.29-1.99) and EBV-positive cHL (OR = 1.81, 95% CI 1.27-2.56) among current smokers, whereas risk of nodular sclerosis (OR = 1.09, 95% CI 0.90-1.32) and EBV-negative HL (OR = 1.02, 95% CI 0.72-1.44) was not increased. Conclusion: These results support the notion of etiologic heterogeneity between HL subtypes, highlighting the need for HL stratification in future studies. Even if not relevant to all subtypes, our study emphasizes that cigarette smoking should be added to the few modifiable HL risk factors identified.",
author = "Mads Kamper-J{\o}rgensen and K Rostgaard and Glaser, {S L} and Zahm, {S H} and W Cozen and Smedby, {K E} and S Sanjos{\'e} and Chang, {E T} and T Zheng and {La Vecchia}, C and D Serraino and A Monnereau and Kane, {E V} and L Miligi and P Vineis and Spinelli, {J J} and McLaughlin, {J R} and P Pahwa and Dosman, {J A} and M Vornanen and L Foretova and M Maynadie and A Staines and N Becker and A Nieters and P Brennan and P Boffetta and P Cocco and H Hjalgrim",
year = "2013",
month = sep,
doi = "10.1093/annonc/mdt218",
language = "English",
journal = "Annals of oncology : official journal of the European Society for Medical Oncology / ESMO",
issn = "0923-7534",
publisher = "Oxford University Press",
}
TY - JOUR
T1 - Cigarette smoking and risk of Hodgkin lymphoma and its subtypes
T2 - a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph)
AU - Kamper-Jørgensen, Mads
AU - Rostgaard, K
AU - Glaser, S L
AU - Zahm, S H
AU - Cozen, W
AU - Smedby, K E
AU - Sanjosé, S
AU - Chang, E T
AU - Zheng, T
AU - La Vecchia, C
AU - Serraino, D
AU - Monnereau, A
AU - Kane, E V
AU - Miligi, L
AU - Vineis, P
AU - Spinelli, J J
AU - McLaughlin, J R
AU - Pahwa, P
AU - Dosman, J A
AU - Vornanen, M
AU - Foretova, L
AU - Maynadie, M
AU - Staines, A
AU - Becker, N
AU - Nieters, A
AU - Brennan, P
AU - Boffetta, P
AU - Cocco, P
AU - Hjalgrim, H
PY - 2013/9
Y1 - 2013/9
N2 - Background: The etiology of Hodgkin lymphoma (HL) remains incompletely characterized. Studies of the association between smoking and HL have yielded ambiguous results, possibly due to differences between HL subtypes. Patients and methods: Through the InterLymph Consortium, 12 case-control studies regarding cigarette smoking and HL were identified. Pooled analyses on the association between smoking and HL stratified by tumor histology and Epstein-Barr virus (EBV) status were conducted using random effects models adjusted for confounders. Analyses included 3335 HL cases and 14 278 controls. Results: Overall, 54.5% of cases and 57.4% of controls were ever cigarette smokers. Compared with never smokers, ever smokers had an odds ratio (OR) of HL of 1.10 [95% confidence interval (CI) 1.01-1.21]. This increased risk reflected associations with mixed cellularity cHL (OR = 1.60, 95% CI 1.29-1.99) and EBV-positive cHL (OR = 1.81, 95% CI 1.27-2.56) among current smokers, whereas risk of nodular sclerosis (OR = 1.09, 95% CI 0.90-1.32) and EBV-negative HL (OR = 1.02, 95% CI 0.72-1.44) was not increased. Conclusion: These results support the notion of etiologic heterogeneity between HL subtypes, highlighting the need for HL stratification in future studies. Even if not relevant to all subtypes, our study emphasizes that cigarette smoking should be added to the few modifiable HL risk factors identified.
AB - Background: The etiology of Hodgkin lymphoma (HL) remains incompletely characterized. Studies of the association between smoking and HL have yielded ambiguous results, possibly due to differences between HL subtypes. Patients and methods: Through the InterLymph Consortium, 12 case-control studies regarding cigarette smoking and HL were identified. Pooled analyses on the association between smoking and HL stratified by tumor histology and Epstein-Barr virus (EBV) status were conducted using random effects models adjusted for confounders. Analyses included 3335 HL cases and 14 278 controls. Results: Overall, 54.5% of cases and 57.4% of controls were ever cigarette smokers. Compared with never smokers, ever smokers had an odds ratio (OR) of HL of 1.10 [95% confidence interval (CI) 1.01-1.21]. This increased risk reflected associations with mixed cellularity cHL (OR = 1.60, 95% CI 1.29-1.99) and EBV-positive cHL (OR = 1.81, 95% CI 1.27-2.56) among current smokers, whereas risk of nodular sclerosis (OR = 1.09, 95% CI 0.90-1.32) and EBV-negative HL (OR = 1.02, 95% CI 0.72-1.44) was not increased. Conclusion: These results support the notion of etiologic heterogeneity between HL subtypes, highlighting the need for HL stratification in future studies. Even if not relevant to all subtypes, our study emphasizes that cigarette smoking should be added to the few modifiable HL risk factors identified.
U2 - 10.1093/annonc/mdt218
DO - 10.1093/annonc/mdt218
M3 - Journal article
C2 - 23788758
SN - 0923-7534
JO - Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
JF - Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
ER -
